Xuelei Ma Md
Clinical trials sponsored by Xuelei Ma Md, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- A randomized controlled trial of Serine/Glycine-Restricted diet combined with chemoradiotherapy and immunotherapy for neoadjuvant treatment of rectal cancer Results expected Jan 2027 (estimated)
-
New surveillance strategy aims to catch residual cancer early in High-Risk nasopharyngeal carcinoma
Disease control Not yet recruitingThis trial tests a follow-up strategy for people with nasopharyngeal cancer that has spread to neck lymph nodes (N3) after radiation therapy. Participants are assigned to standard follow-up or an enhanced approach that uses advanced imaging and a blood test (EBV DNA) to decide if…
Sponsor: Xuelei Ma MD • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
A randomized controlled trial of Serine/Glycine-Restricted diet combined with chemoradiotherapy and immunotherapy for neoadjuvant treatment of rectal cancer
Not yet recruitingThis is a Phase Ib/II seamless, open-label, randomized controlled trial evaluating the safety and efficacy of a serine/glycine-restricted diet combined with neoadjuvant chemoradiotherapy and immunotherapy in patients with locally advanced rectal cancer (LARC). The study consists…
Phase 1/2 • Sponsor: Xuelei Ma MD
Last updated Sep 10, 2026 01:00 UTC